Related Experiment Video
Updated: Mar 19, 2026
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
13.2K
Multitargeted bioactive ligands for PPARs discovered in the last decade.
Jun Zhang1, Xin Liu1, Xian-Bin Xie1
1Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
Chemical Biology & Drug Design
|June 19, 2016
Summary
New PPAR agonists target multiple pathways to treat metabolic disorders like type 2 diabetes, aiming for better efficacy and fewer side effects than older drugs.
Area of Science:
- Pharmacology and Medicinal Chemistry
- Metabolic Disease Research
- Molecular Biology
Background:
- Type 2 diabetes is characterized by insulin resistance, a key target for metabolic disorder therapies.
- Peroxisome proliferator-activated receptors (PPARs) are crucial targets for treating obesity, hypertension, diabetes, and cardiovascular disease.
- Previous PPARγ agonists like rosiglitazone faced clinical restrictions due to severe side effects linked to selective agonism.
Purpose of the Study:
- To review the development of multitarget-directed PPAR agonists over the past decade.
- To explore novel PPAR modulators (partial agonists, antagonists, dual agonists, pan-agonists) for metabolic disorders.
- To highlight agents with potential synergistic effects and reduced side effects compared to selective agonists.
Main Methods:
- Comprehensive literature review of PPAR modulator development from the last decade.
- Analysis of molecules derived from known structures and high-throughput screening.
- Categorization of PPAR modulators including partial agonists, antagonists, dual agonists, and pan-agonists.
Main Results:
- Significant progress in designing diverse PPAR modulators: PPARγ partial agonists, PPARγ antagonists, PPARα/γ dual agonists, PPARδ partial agonists, PPARδ antagonists, PPARα/δ dual agonists, PPARγ/δ dual agonists, and PPARα/γ/δ pan-agonists.
- Many novel compounds were developed through structural modification of existing drugs or via high-throughput screening.
- Identified several promising molecules with potential for treating metabolic disorders.
Conclusions:
- Multitarget-directed PPAR agonists represent a promising strategy for developing effective treatments for metabolic disorders.
- These novel agents offer potential for synergistic therapeutic effects with improved safety profiles.
- The reviewed compounds provide valuable insights for the future design of next-generation PPAR-based therapeutics.
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
5.1K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.1K
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:15G Protein-coupled Receptors
19.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.3K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.8K
01:26Targets for Drug Action: Overview
11.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
02:40Ligand Binding Sites
15.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K